Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combination of Radioimmunotherapy”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Early research (Phase 1)Ended earlyNCT03118349
What this trial is testing

Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy

Who this might be right for
Pancreatic CarcinomaTumors That Express CA 19-9
BioNTech Research & Development, Inc. 4
Testing effectiveness (Phase 2)Looking for participantsNCT06947694
What this trial is testing

A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases

Who this might be right for
NSCLC Stage IV Without EGFR/ALK Mutation
Xinqiao Hospital of Chongqing 427
Early research (Phase 1)Looking for participantsNCT03467360
What this trial is testing

Phase I Trial of CArbonic Anhydrase Inhibition in Combination With Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma

Who this might be right for
Small Cell Lung Cancer
Centre Antoine Lacassagne 27
Not applicableLooking for participantsNCT07240610
What this trial is testing

Abscopal Effect of Ultra-Hypofractionated Radiation Plus Immunotherapy in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Cancer Metastatic
Zhe Chen 145
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07059949
What this trial is testing

Short Course Radiotherapy Followed by CAPOX and Carrilizumab and Bevacizumab or Cetuximab for the Initial Treatment of Unresectable Metastatic Rectal Cancer

Who this might be right for
Unresectable Metastatic Rectal CancerCAPOXCombination of Radioimmunotherapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 80
Early research (Phase 1)Not Yet RecruitingNCT06966583
What this trial is testing

NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC

Who this might be right for
Solid TumorNon Small Cell Lung Cancer
Sichuan University 20
Early research (Phase 1)WithdrawnNCT04466475
What this trial is testing

Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma

Who this might be right for
Plasma Cell Myeloma
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00450827
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT01147393
What this trial is testing

Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Weill Medical College of Cornell University 4
Testing effectiveness (Phase 2)Ended earlyNCT01468311
What this trial is testing

Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma

Who this might be right for
Hodgkin DiseaseHodgkin Lymphoma
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Study completedNCT00514475
What this trial is testing

Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Oslo University Hospital 160
Early research (Phase 1)Study completedNCT03806179
What this trial is testing

Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL

Who this might be right for
Non Hodgkin LymphomaFollicular LymphomaRelapsed Follicular Lymphoma
Nordic Nanovector 7
Early research (Phase 1)UnknownNCT00009776
What this trial is testing

Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of California, Davis
Early research (Phase 1)UnknownNCT00009763
What this trial is testing

Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of California, Davis
Testing effectiveness (Phase 2)Study completedNCT03161379
What this trial is testing

GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT04022213
What this trial is testing

The Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum

Who this might be right for
Desmoplastic Small Round Cell TumorPeritoneal CancerPeritoneal Carcinoma
Memorial Sloan Kettering Cancer Center 31
Early research (Phase 1)Study completedNCT00738452
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy

Who this might be right for
Lung Cancer
City of Hope Medical Center 10
Testing effectiveness (Phase 2)UnknownNCT01192087
What this trial is testing

Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy

Who this might be right for
Adenoid Cystic Carcinoma
Heidelberg University 49
Early research (Phase 1)Ended earlyNCT01124812
What this trial is testing

131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Philogen S.p.A. 3
Testing effectiveness (Phase 2)Study completedNCT01125085
What this trial is testing

131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors

Who this might be right for
Brain Metastases From Solid Tumors
Philogen S.p.A. 32
Load More Results